Shedding Light on the Risks
& Benefits of Medications 
Simtriyo is being promoted as a new kind of ADHD drug that may help with emotional dysregulation. But the strongest evidence so far is for core ADHD symptoms, and questions remain about how it compares to existing treatments
Sep 11, 2026
Scientists have identified genetic variants that make certain medications far more toxic for some people. The challenge is getting that information into the exam room
Sep 1, 2026
Could some cancer patients get the same benefit from less medication? Researchers are challenging standard doses that can bring serious side effects and staggering costs.
Aug 27, 2026
Rapamycin has become a favorite among longevity enthusiasts. Now, some fertility specialists are prescribing it off-label to improve IVF outcomes, while others say the evidence isn't strong enough to justify its use
Aug 21, 2026
I took the “gentle” stool softener for nearly two months during pregnancy — then learned there’s little evidence it works better than a placebo
Aug 18, 2026
A new oral PCSK9 inhibitor may lower cholesterol by more than half when added to statins and other existing treatments, but whether it prevents heart attacks and strokes remains unknown
Aug 5, 2026
New Medicare guidance could expand access to pharmacist-led care that helps people safely reduce or stop medications that may no longer benefit them
Jul 28, 2026
Generics save families money and work well for most medications. But for seizure drugs, some ADHD medications, and a few other treatments, consistency can be important
Jun 24, 2026
Stevens-Johnson syndrome is frequently misdiagnosed in its early stages, delaying treatment and increasing the risk of life-altering complications
Jun 11, 2026
As online weight-loss clinics boom, reports of GLP-1 overdoses, dosing mistakes, and hospitalizations are climbing
Jun 3, 2026
Once promoted as a COVID-19 treatment, ivermectin — along with the veterinary drug fenbendazole — is now being touted online as a cancer cure, driven by viral anecdotes and early research that scientists say falls far short of proof
Apr 30, 2026
When a political promise outpaces science, families start making decisions based on evidence that never existed
Apr 22, 2026
Widely used off-label to steady nerves, beta-blockers can blunt the body’s stress response. But the evidence is limited, the benefits are specific, and the risks — while often low — are real
Apr 16, 2026
In medicine, “do your own research” sounds empowering, but too often, it becomes a shortcut to misinformation, fear, and false certainty
Apr 1, 2026
Online teleprescribing platforms promise fast access to medication. Critics say the model can bypass safeguards and leave patients in the dark about risks
Mar 26, 2026
After decades of debate, politicians of all stripes are proposing bans
Mar 2, 2026
A large Lancet review finds little evidence for most risks, but some researchers say limited access to the data raises questions
Feb 19, 2026
OTC painkillers are widely seen as safe. But frequent, unsupervised use can sometimes make chronic pain harder to treat
Jan 22, 2026
In response to a MedShadow investigation, patients describe how inconsistent opioid quality can turn daily life upside down, and why many are afraid to report it
Jan 13, 2026
Diphenhydramine is linked to severe and sometimes fatal side effects, yet remains widely sold over the counter. Physicians argue that safer alternatives exist, and question why the drug is still so easy to buy
Jan 6, 2026
Stream our library on demand, including insights on generic drugs and pain management, straight from experts.
WATCH NOW
